Company / Operating Income
Harmony Biosciences Holdings, Inc. Operating Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$208.5M
FY2025
5-year range
-$145.9M / $208.5M
FY2021-FY2025
Trend
+9.2%
vs FY2024
Sector context
#26 of 204
Health Care
What the data says
Harmony Biosciences Holdings, Inc.'s operating income of $208M is higher than 87% of companies in the Health Care sector (FY2025). Improved from $192M to $208M over the past 2 years.
Based on SEC 10-K filings.
$208M in FY2025 with a 3-year CAGR of +20.2%. Top quartile in the Health Care sector.
Improved from $192M to $208M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- +20.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 204This company $208.5M Sector average $107.8M
▼
+93.5% above sector average
Key checks
Key Insights
- 3-year CAGR of +20.2%, indicating consistent growth.
- In FY2025, operating income increased 9.2% year-over-year.
- Ranks #26 out of 204 companies in the Health Care sector.
- Lowest operating income in the period was in FY2021.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $208.5M | +9.2% |
| FY2024 | $190.8M | -0.6% |
| FY2023 | $192.0M | +59.8% |
| FY2022 | $120.2M | +182.4% |
| FY2021 | -$145.9M | +0.0% |
| FY2020 | -$145.9M | +0.0% |
| FY2019 | -$145.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026